$CVRX
CVRx, Inc.

2021 Q4 Form 10-Q Financial Statement

#000155837021014953 Filed on November 08, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q4
Revenue $3.658M $3.395M $2.088M
YoY Change 75.19% 240.52%
Cost Of Revenue $984.0K $876.0K $451.0K
YoY Change 118.18% 313.21%
Gross Profit $2.674M $2.519M $1.637M
YoY Change 63.35% 220.89%
Gross Profit Margin 73.1% 74.2% 78.4%
Selling, General & Admin $9.665M $8.111M $3.262M
YoY Change 196.29% 248.56%
% of Gross Profit 361.44% 321.99% 199.27%
Research & Development $1.797M $1.699M $510.0K
YoY Change 252.35% 13.27%
% of Gross Profit 67.2% 67.45% 31.15%
Depreciation & Amortization $56.00K $42.00K $23.00K
YoY Change 143.48% 147.06%
% of Gross Profit 2.09% 1.67% 1.41%
Operating Expenses $11.46M $9.810M $3.772M
YoY Change 203.87% 156.34%
Operating Profit -$8.788M -$7.291M -$2.135M
YoY Change 311.62% 139.68%
Interest Expense -$396.0K $614.0K -$614.0K
YoY Change -35.5% -1.13%
% of Operating Profit
Other Income/Expense, Net -$2.661M $1.795M -$632.0K
YoY Change 321.04% 294.51%
Pretax Income -$10.55M -$6.110M -$3.381M
YoY Change 211.89% 90.46%
Income Tax $25.00K $23.00K $21.00K
% Of Pretax Income
Net Earnings -$10.57M -$6.133M -$3.402M
YoY Change 210.7% 90.05%
Net Earnings / Revenue -288.96% -180.65% -162.93%
Basic Earnings Per Share -$0.30
Diluted Earnings Per Share -$1.020M -$317.9K -$44.77K
COMMON SHARES
Basic Shares Outstanding 20.35M 20.35M
Diluted Shares Outstanding 20.13M

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $142.1M $170.9M
YoY Change
Cash & Equivalents $142.1M $170.9M $59.11M
Short-Term Investments
Other Short-Term Assets $2.585M $2.923M
YoY Change
Inventory $3.880M $3.440M $3.343M
Prepaid Expenses
Receivables $2.560M $3.421M $1.281M
Other Receivables $0.00 $0.00
Total Short-Term Assets $151.1M $180.7M $64.34M
YoY Change 134.84%
LONG-TERM ASSETS
Property, Plant & Equipment $1.425M $943.0K $410.0K
YoY Change 247.56%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $26.00K $67.00K $26.00K
YoY Change 0.0%
Total Long-Term Assets $1.451M $1.010M $436.0K
YoY Change 232.8%
TOTAL ASSETS
Total Short-Term Assets $151.1M $180.7M $64.34M
Total Long-Term Assets $1.451M $1.010M $436.0K
Total Assets $152.5M $181.7M $64.78M
YoY Change 135.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $510.0K $541.0K $483.0K
YoY Change 5.59%
Accrued Expenses $5.398M $4.977M $3.583M
YoY Change 50.66%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $3.333M $0.00
YoY Change
Total Short-Term Liabilities $5.908M $8.851M $7.977M
YoY Change -25.94%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $16.15M $19.28M
YoY Change -100.0%
Other Long-Term Liabilities $681.0K $941.0K $777.0K
YoY Change -12.36%
Total Long-Term Liabilities $681.0K $17.09M $20.06M
YoY Change -96.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.908M $8.851M $7.977M
Total Long-Term Liabilities $681.0K $17.09M $20.06M
Total Liabilities $6.589M $25.94M $28.03M
YoY Change -76.49%
SHAREHOLDERS EQUITY
Retained Earnings -$394.8M -$384.2M -$351.7M
YoY Change 12.25%
Common Stock $540.9M $540.1M $58.63M
YoY Change 822.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $146.0M $155.8M -$293.2M
YoY Change
Total Liabilities & Shareholders Equity $152.5M $181.7M $64.78M
YoY Change 135.5%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q4
OPERATING ACTIVITIES
Net Income -$10.57M -$6.133M -$3.402M
YoY Change 210.7% 90.05%
Depreciation, Depletion And Amortization $56.00K $42.00K $23.00K
YoY Change 143.48% 147.06%
Cash From Operating Activities -$7.015M -$9.215M -$4.084M
YoY Change 71.77% 78.69%
INVESTING ACTIVITIES
Capital Expenditures -$538.0K -$165.0K -$101.0K
YoY Change 432.67% 39.83%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$538.0K -$165.0K -$101.0K
YoY Change 432.67% 39.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -21.29M 133.2M 0.000
YoY Change 167.5%
NET CHANGE
Cash From Operating Activities -7.015M -9.215M -4.084M
Cash From Investing Activities -538.0K -165.0K -101.0K
Cash From Financing Activities -21.29M 133.2M 0.000
Net Change In Cash -28.84M 123.8M -4.185M
YoY Change 589.13% 178.13%
FREE CASH FLOW
Cash From Operating Activities -$7.015M -$9.215M -$4.084M
Capital Expenditures -$538.0K -$165.0K -$101.0K
Free Cash Flow -$6.477M -$9.050M -$3.983M
YoY Change 62.62% 79.6%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6975386
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001235912
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Amendment Flag
AmendmentFlag
false
CY2021Q3 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2020Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
360412
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20351779
CY2020Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
223541754
CY2021Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.025
CY2021Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
223541754
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
360412
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40545
dei Entity Registrant Name
EntityRegistrantName
CVRx, Inc
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
41-1983744
dei Entity Address Address Line1
EntityAddressAddressLine1
9201 West Broadway Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 650
CY2020Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.01
dei Entity Address City Or Town
EntityAddressCityOrTown
Minneapolis
dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55445
dei City Area Code
CityAreaCode
763
dei Local Phone Number
LocalPhoneNumber
416-2840
dei Security12b Title
Security12bTitle
Common stock,
dei Trading Symbol
TradingSymbol
CVRX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20351779
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
170913000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
59112000
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3421000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1281000
CY2021Q3 us-gaap Inventory Net
InventoryNet
3440000
CY2020Q4 us-gaap Inventory Net
InventoryNet
3343000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2923000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
605000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
180697000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
64341000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
943000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
410000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
67000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
26000
CY2021Q3 us-gaap Assets
Assets
181707000
CY2020Q4 us-gaap Assets
Assets
64777000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
541000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
483000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4977000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3583000
CY2021Q3 cvrx Warrant Liability Current
WarrantLiabilityCurrent
0
CY2020Q4 cvrx Warrant Liability Current
WarrantLiabilityCurrent
3911000
CY2021Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
3333000
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
8851000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7977000
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
16151000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
19278000
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
941000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
777000
CY2021Q3 us-gaap Liabilities
Liabilities
25943000
CY2020Q4 us-gaap Liabilities
Liabilities
28032000
CY2021Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1699000
CY2021Q3 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
10000000
CY2020Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
237370645
CY2021Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0
CY2021Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
329983000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
625217795
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20351779
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
204000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
4000
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
539941000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
58624000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-384184000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-351676000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-197000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-190000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
155764000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-293238000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
181707000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
64777000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3395000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
997000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9378000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3965000
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
876000
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
212000
us-gaap Cost Of Revenue
CostOfRevenue
2656000
us-gaap Cost Of Revenue
CostOfRevenue
989000
CY2021Q3 us-gaap Gross Profit
GrossProfit
2519000
CY2020Q3 us-gaap Gross Profit
GrossProfit
785000
us-gaap Gross Profit
GrossProfit
6722000
us-gaap Gross Profit
GrossProfit
2976000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1500000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5704000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5900000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8111000
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2327000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18198000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6455000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
9810000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
3827000
us-gaap Operating Expenses
OperatingExpenses
23902000
us-gaap Operating Expenses
OperatingExpenses
12355000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7291000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3042000
us-gaap Operating Income Loss
OperatingIncomeLoss
-17180000
us-gaap Operating Income Loss
OperatingIncomeLoss
-9379000
CY2021Q3 us-gaap Interest Expense
InterestExpense
614000
CY2020Q3 us-gaap Interest Expense
InterestExpense
621000
us-gaap Interest Expense
InterestExpense
1823000
us-gaap Interest Expense
InterestExpense
1856000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1795000
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
455000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-13439000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
592000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6110000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3208000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-32442000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10643000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
66000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
64000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-6133000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-3227000
us-gaap Net Income Loss
NetIncomeLoss
-32508000
us-gaap Net Income Loss
NetIncomeLoss
-10707000
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-3000
CY2020Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
14000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-8000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-7000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6136000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3213000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-32516000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10714000
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.30
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-9.56
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-4.66
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-27.58
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20126672
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
360356
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6975386
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
396071
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-318931000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
474000
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
133161000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Stock Split
AdjustmentsToAdditionalPaidInCapitalStockSplit
1000
CY2021Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
347188000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-6133000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
155764000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-286480000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
31000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
217000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-3227000
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
14000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-289879000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-293238000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1159000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
133161000
us-gaap Adjustments To Additional Paid In Capital Stock Split
AdjustmentsToAdditionalPaidInCapitalStockSplit
1000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
347188000
us-gaap Net Income Loss
NetIncomeLoss
-32508000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
155764000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-279043000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
95000
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
217000
us-gaap Net Income Loss
NetIncomeLoss
-10707000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-289879000
us-gaap Net Income Loss
NetIncomeLoss
-32508000
us-gaap Net Income Loss
NetIncomeLoss
-10707000
us-gaap Share Based Compensation
ShareBasedCompensation
1159000
us-gaap Share Based Compensation
ShareBasedCompensation
95000
us-gaap Depreciation
Depreciation
112000
us-gaap Depreciation
Depreciation
52000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
206000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
217000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
13294000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-387000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2140000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-138000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
97000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1243000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2359000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
241000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
58000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
228000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1558000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-164000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20717000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12012000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
645000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
210000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-645000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-210000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
0
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
49783000
cvrx Payments Related To Reverse Stock Split
PaymentsRelatedToReverseStockSplit
1000
cvrx Payments Related To Reverse Stock Split
PaymentsRelatedToReverseStockSplit
0
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
133161000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
133170000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
49783000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-7000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-7000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
111801000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
37554000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59112000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25741000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
170913000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
63295000
us-gaap Interest Paid Net
InterestPaidNet
1522000
us-gaap Interest Paid Net
InterestPaidNet
1528000
us-gaap Income Taxes Paid
IncomeTaxesPaid
1000
us-gaap Income Taxes Paid
IncomeTaxesPaid
10000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Use of estimates</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results could differ from those estimates.</p>
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2755000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2110000
CY2021Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
1083000
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1361000
CY2021Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
287000
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
321000
CY2021Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2070000
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1661000
CY2021Q3 us-gaap Inventory Net
InventoryNet
3440000
CY2020Q4 us-gaap Inventory Net
InventoryNet
3343000
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1812000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1700000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
943000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
410000
CY2021Q3 us-gaap Depreciation
Depreciation
42000
CY2020Q3 us-gaap Depreciation
Depreciation
17000
us-gaap Depreciation
Depreciation
112000
us-gaap Depreciation
Depreciation
52000
CY2021Q3 cvrx Clinical Trial And Other Professional Fees
ClinicalTrialAndOtherProfessionalFees
1638000
CY2020Q4 cvrx Clinical Trial And Other Professional Fees
ClinicalTrialAndOtherProfessionalFees
1690000
CY2021Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1628000
CY2020Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
794000
CY2021Q3 cvrx Accrued Paid Time Off
AccruedPaidTimeOff
723000
CY2020Q4 cvrx Accrued Paid Time Off
AccruedPaidTimeOff
552000
CY2021Q3 us-gaap Interest Payable Current
InterestPayableCurrent
451000
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
356000
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
537000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
191000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4977000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3583000
CY2021Q3 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2020Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
5333000
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
8000000
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
6667000
CY2021Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
20000000
CY2021Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
516000
CY2021Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
3333000
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
16151000
CY2021Q3 us-gaap Preferred Stock Convertible Conversion Ratio
PreferredStockConvertibleConversionRatio
39.548
CY2021Q3 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
11929584
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1473359
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.64
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1238426
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
13.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
42669
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
10.31
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
11783
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.88
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2657333
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.35
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
25475000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1009785
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.36
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
14330000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y4M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y3M18D
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20126672
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.25
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.561
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.634
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0017
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0047
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
474000
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
31000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1159000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
95000
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
6300000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y6M
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
66000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
64000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-6133000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-3227000
us-gaap Net Income Loss
NetIncomeLoss
-32508000
us-gaap Net Income Loss
NetIncomeLoss
-10707000
CY2020Q3 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
217000
us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
217000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6133000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3444000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-32508000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10924000
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
360356
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
396071
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.30
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-9.56
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-4.66
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-27.58
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3373464
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12999875
CY2021Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
91000
CY2020Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
90000
us-gaap Operating Lease Expense
OperatingLeaseExpense
279000
us-gaap Operating Lease Expense
OperatingLeaseExpense
276000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
56000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
227000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
234000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
138000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
655000
CY2021Q3 us-gaap Contractual Obligation
ContractualObligation
0
CY2020Q4 us-gaap Contractual Obligation
ContractualObligation
0
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3395000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
997000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9378000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3965000

Files In Submission

Name View Source Status
0001558370-21-014953-index-headers.html Edgar Link pending
0001558370-21-014953-index.html Edgar Link pending
0001558370-21-014953.txt Edgar Link pending
0001558370-21-014953-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmb-20210930.xsd Edgar Link pending
tmb-20210930x10q.htm Edgar Link pending
tmb-20210930x10q_htm.xml Edgar Link completed
tmb-20210930xex31d1.htm Edgar Link pending
tmb-20210930xex31d2.htm Edgar Link pending
tmb-20210930xex32d1.htm Edgar Link pending
tmb-20210930xex32d2.htm Edgar Link pending
tmb-20210930_cal.xml Edgar Link unprocessable
tmb-20210930_def.xml Edgar Link unprocessable
tmb-20210930_lab.xml Edgar Link unprocessable
tmb-20210930_pre.xml Edgar Link unprocessable